Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025
DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after covalent or non-covalent BTK inhibitors and BTK degraders was selected for oral presentation
Dizal will also present results from the ongoing Phase I/II study of DZD6008, a 4th generation EGFR TKI with full BBB penetration, in advanced EGFR mutation positive (EGFRm) non-small cell lung cancer (NSCLC)
SHANGHAI, April 24, 2025 /PRNewswire/ — Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting will feature the latest study results from the company's investigational drugs DZD8586 and DZD6008 in B-cell non-Hodgkin lymphomas (B-NHLs) and non-small cell lung cancer (NSCLC).
The oral presentation includes results in B-NHLs from a pooled safety and efficacy analysis of two phase I/Ⅱ studies of DZD8586 in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients with prior treatment of covalent and/or non-covalent BTK Inhibitors as well as BTK degraders.
While early clinical data showed encouraging anti-tumor activities from BTK degraders in CLL/SLL patients, resistance mutations to both BTK inhibitors and degraders have already been reported, and degrader-related toxicities may affect long-term clinical application. Data from Phase I/II studies of DZD8586 in CLL/SLL, presented at the 66th American Society of Hematology (ASH) Annual Meeting, showed that 94.4% of patients achieved tumor shrinkage at ≥50 mg QD. Significant tumor responses were also observed in other B-NHLs, including diffuse large B-cell lymphoma (DLBCL). Preliminary results from the ongoing phase Ⅱ study of DZD8586 monotherapy in patients with relapsed/refractory DLBCL will be presented at this ASCO meeting.
Dizal will also present Phase I/II data of DZD6008, a 4th generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with full blood–brain barrier (BBB) penetration, in advanced EGFR mutation positive (EGFRm) NSCLC patients who failed prior 3rd generation EGFR TKI treatment. Lung cancer is a leading cause of brain metastases (BMs), with 10-20% of patients with NSCLC presenting with BMs at diagnosis and 25-50% developing them over the course of their disease. NSCLC patients whose disease progressed after 3rd generation EGFR TKI treatment often develop CNS metastasis and exhibit acquired EGFR resistance mutations. Preclinical data shows that DZD6008 demonstrates good safety and efficacy in NSCLC patients with brain metastases who had failed 3rd generation EGFR TKI therapy or multiple lines of pre-treatments.
'We are honored that our study results have been selected for oral presentations at ASCO for three consecutive years. Our presence at this congress highlights our commitment to addressing global unmet medical needs in hematological malignancies and lung cancer,' said Xiaolin Zhang, PhD, CEO of Dizal. 'We look forward to sharing positive clinical data of our novel medicines, which have the potential to bring clinical benefit to patients with limited treatment options.'
Dizal presentation details during ASCO 2025：
Lead Author
Abstract Title
Presentation Details
Prof. Jianyong Li
Phase 1/2 Studies of DZD8586 in CLL/SLL Patients after Covalent or Non-covalent BTK Inhibitors and BTK Degraders
Abstract #7010
Rapid Oral Abstract Session
May 31, 2025, 8:00-9:30 (CDT)
Prof. Mengzhao Wang
Phase 1/2 Study of DZD6008, a 4th-Generation EGFR TKI with Full BBB Penetration, in EGFR-mutant NSCLC
Abstract #8616
Poster Session
May 31, 2025, 13:30-16:30 (CDT)
Prof. Lugui Qiu
Phase 2 Study of DZD8586, a Non-Covalent BBB Penetrant LYN/BTK Dual Inhibitor, as Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) (TAI-SHAN9)
Abstract #e19050
Online Publication
May 22, 2025, 17:00 (EDT)
About DZD8586DZD8586 is a first-in-class, non-covalent, LYN/BTK dual inhibitor with full blood-brain barrier (BBB) penetration, designed as a potential treatment option for B-cell non-Hodgkin lymphoma (B-NHL).
While Bruton's Tyrosine Kinase (BTK) inhibitors have been approved for the treatment of B-NHL, resistance can arise through two major mechanisms: the BTK C481X mutation and BTK-independent BCR signaling pathway activation. Currently, there is no targeted therapy available to address both resistance mechanisms, posing an urgent clinical challenge. Although BTK degraders have shown encouraging efficacy in early clinical studies, mutation-related resistance has been reported, and degrader-related toxicities may affect long-term clinical application.
DZD8586 has high selectivity against other TEC family kinases (TEC, ITK, TXK and BMX). By targeting BTK and LYN, it blocks both BTK-dependent and -independent BCR-signaling pathways, effectively inhibiting tumor growth of B-NHLs in cell lines and in animal models. Phase I clinical trial suggests that DZD8586 exhibits favorable PK properties, good central nervous system (CNS) permeability, complete blockade of BCR signaling, and encouraging anti-tumor efficacy with good safety and tolerability in patients with B-NHL.
About DZD6008DZD6008 is a novel, highly selective, full-BBB penetrant EGFR TKI, designed as a potential treatment option for advanced EGFR mutation positive (EGFRm) NSCLC.
Non-small cell lung cancer is the leading cause of cancer death in the world. Epidermal growth factor receptor (EGFR) gene is one of the most common driver genes for NSCLC. Multiple agents can be used to treat patients with EGFR mutated NSCLC who develop resistance to EGFR tyrosine kinase inhibitors (TKIs), but the clinical outcome was not satisfactory. Brain metastases (BM) are a leading cause of death and disease progression for NSCLC. Approximately 23%-30% of NSCLC patients are synchronous BM at their initial diagnosis. Previous studies reported that the 3-year cumulative rate of BMs ranges from 29.4% to 60.3% in patients with mutated EGFR.
Currently, the clinical benefits of existing treatments for third-generation EGFR TKI-resistant NSCLC are limited and DZD6008 is expected to fill the unmet medical needs. DZD6008 effectively inhibits EGFR-mutated tumor growth in cell lines and in animal models. Previous clinical studies have validated the design concept of the molecule and suggest that DZD6008 demonstrates good safety and efficacy in NSCLC patients with brain metastases who had failed third-generation EGFR TKI therapy or multiple lines of pre-treatments.
About DizalDizal is a biopharmaceutical company, dedicated to the discovery, development and commercialization of differentiated therapeutics for the treatment of cancer and immunological diseases. The company aims to develop first-in-class and groundbreaking new medicines, and further address unmet medical needs worldwide. Deeply rooted in translational science and molecular design, it has established an internationally competitive portfolio with two leading assets in global pivotal studies, both of which have already been launched in China.
To learn more about Dizal, please visit www.dizalpharma.com, or follow us on Linkedin or X.
Forward-Looking StatementsThis news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words 'anticipate', 'believe', 'estimate', 'expect', and 'intend' and similar expressions, as they relate to Dizal, are intended to identify certain forward-looking statements. Dizal does not intend to update these forward-looking statements regularly.
These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections, and understandings of the management of Dizal with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties, and other factors, some of which are beyond Dizal's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Dizal's competitive environment, and political, economic, legal, and social conditions.
Dizal, the Directors, and the employees of Dizal assume (a) no obligation to correct or update the forward-looking statements contained on this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turnout to be incorrect.
ContactsInvestor Relations: ir@dizalpharma.com Business Development: bd@dizalpharma.com Media Contact: pr@dizalpharma.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
Electromechanical Actuators in Aircraft Market worth $804.3 million by 2030
DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ — The electromechanical actuators in aircraft market is projected to reach USD 804.3 million by 2030, growing from USD 577.1 million in 2025 at a CAGR of 6.9% according to a new report by MarketsandMarkets™. The electromechanical actuators in aircraft market is witnessing strong momentum, fueled by rapid advancements in power electronics, smart sensors, and digital control systems. The growing focus on more electric aircraft (MEA) concepts, which aim to improve energy efficiency and reduce dependency on hydraulic and pneumatic systems, is accelerating the adoption of EMAs. The rising demand for lightweight, maintenance-friendly, and environmentally sustainable solutions encourages innovation in commercial and military aviation. At the same time, evolving defense modernization programs and next-generation aircraft platforms are opening up new opportunities for advanced actuation technologies. Aircraft manufacturers and system integrators increasingly invest in cutting-edge EMA solutions to meet performance, safety, and cost targets. With technology becoming more integrated and platforms more electric, the market is poised for long-term growth. It remains a critical enabler of the aviation industry's shift toward more innovative, cleaner, and reliable systems. Download PDF Brochure: Browse in-depth TOC on 'Electromechanical Actuators in Aircraft Market' 200 – Tables80 – Figures230 – Pages Electromechanical Actuators in Aircraft Market Report Scope: Report Coverage Details Market Revenue in 2025 $ 577.1 million Estimated Value by 2030 $ 804.3 million Growth Rate Poised to grow at a CAGR of 6.9% Market Size Available for 2020–2030 Forecast Period 2025–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By mechanism type, motor torque, application, platform, and region Geographies Covered North America, Europe, Asia Pacific, and Rest of World Key Market Challenge Power supply and thermal management limitations Key Market Opportunities Advancements in autonomous flight Key Market Drivers Rising adoption of More Electric Aircraft architecture By platform, the narrow-body aircraft segment is projected to account for the largest share of the electromechanical actuators in aircraft market during the forecast period. The dominance of the narrow-body aircraft segment is underpinned by strong global demand for single-aisle jets, especially across commercial airline fleets. With increasing focus on fleet modernization, airlines are upgrading to newer models, such as the Airbus A320neo and Boeing 737 MAX, which integrate advanced electromechanical actuators (EMAs) for flight control surfaces, landing gear operations, and other critical functions. The adoption of EMAs in narrow-body aircraft is primarily driven by their lower weight, better energy efficiency, and reduced maintenance needs compared to traditional hydraulic systems. Given the high production volumes of narrow-body aircraft and their extensive use in short- and medium-haul routes worldwide, this aircraft continues to attract significant EMA integration. Moreover, the push toward more electric aircraft and increasing passenger traffic in emerging markets further reinforce the segment's leading market position. Narrow-body platforms are increasingly seen as the foundation for technological upgrades, which makes them central to the EMA market landscape. By application, the flight control surface segment is projected to account for the largest share during the forecast period. The flight control surface segment is projected to account for a significant market share, driven by the aviation industry's shift toward more electric aircraft and the growing need for precise, lightweight, and energy-efficient actuation systems. These actuators play a vital role in managing the aerodynamic behavior of an aircraft, enabling accurate control of ailerons, elevators, rudders, and flaps. As aircraft designs evolve, the demand for advanced EMAs in primary and secondary flight control systems continues to grow, especially in next-generation commercial jets and military platforms. Reduced maintenance needs, enhanced reliability, and better integration with digital flight control architectures have driven the move from hydraulic systems toward electromechanical solutions. With growing emphasis on performance optimization, weight reduction, and environmental efficiency, EMAs for flight control surfaces have become critical to modern aircraft programs. Inquiry Before Buying: North America is projected to account for the largest share during the forecast period. North America remains at the forefront of the electromechanical actuators in aircraft industry, primarily due to its robust aerospace sector, rich engineering skills base, and drive towards more electric airplane designs. In recent years, there has been a well-documented shift from conventional hydraulic systems toward electromechanical systems, particularly for flight control and landing gear systems. This transformation is fueled by the need to shed weight, increase fuel economy, and make maintenance easier. Industry leaders such as Honeywell, Moog Inc., and Curtiss-Wright are at the forefront of this change, creating more sophisticated and reliable EMA technologies for commercial and defense applications. Regulatory incentives have also played a significant part. The FAA's emphasis on safety and electrification has driven broader usage of EMA systems throughout aging fleets and new airplanes. The region's robust supply base, large aircraft programs, and military modernization continue to drive demand for EMS. With increasing focus on testing, certification, and system integration, North America is emerging as a leading center for electromechanical actuator innovation and deployment. Honeywell International Inc. (US), Curtiss-Wright Corporation (US), Liebherr (Switzerland), and Ametek Inc. (US) are major players in the electromechanical actuators in aircraft companies. These companies have strong distribution networks across North America, Europe, Asia Pacific, the Middle East, and Rest of the World. Get 10% Free Customization on this Report: Browse Adjacent Market: Aerospace and Defence Market Research Reports &Consulting Related Reports: Military Vehicle Electrification Market by Platform (Combat Vehicles, Support Vehicles, Unmanned Armored Vehicles), System, Technology (Hybrid, Fully Electric), Mode of operation, Voltage Type and Region – Global Forecast to 2030 Military Vehicle Sustainment Market by Vehicle Type (Armored Vehicles, Military Trucks), Service (Maintenance, Repair, & Overhaul (MRO), Training & Support, Parts and Components Supply, Upgrades & Modernization), End User, and Region- Global Forecast to 2028 Turret System Market by Type (Manned, Unmanned), Component (Turret Drive, Turret Control System, Stabilization Unit), Platform (Land, Airborne, Naval), and Region – Global Forecast to 2027 Unmanned Ground Vehicles Market by Mobility (Wheeled, Tracked, Hybrid), Application (Military, Commercial, Law Enforcement, Federal Law Enforcement), Size (10-200lbs, 200-500lbs, Others), Mode of Operation, System, and Region-Global Forecast to 2027 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Web Site: Insight: Source: Logo: View original content:
Malaysian Reserve
an hour ago
- Malaysian Reserve
Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025-Exclusive Report by Meticulous Research®
Market Growth Driven by Cold Chain Expansion, IoT Integration, Regulatory Compliance Requirements, and Focus on Food Safety REDDING, Calif., June 20, 2025 /PRNewswire/ — According to a new market research report titled 'Time Temperature Indicator Market by Technology (Chemical, Electronic, Hybrid), Application (Cold Chain, Food, Pharma), End User (F&B, Healthcare) & Geography – Global Forecast to 2035″, the time temperature Indicator market is projected to reach $1.57 billion by 2035, up from an estimated $821 million in 2024, growing at a CAGR of 6.2% during the forecast period. The growth of the time temperature indicator market is mainly driven by the critical importance of precise temperature monitoring throughout the cold chain for temperature-sensitive products valued at over $250 billion annually. Stringent regulations in pharmaceutical industry and expanding e-commerce supply chains are fueling adoption of smart TTI labels with digital integration capabilities. Recent FDA guidelines requiring enhanced temperature monitoring for vaccine distribution and biologics storage have created new compliance-driven demand for Critical Time Temperature Indicators (CTTI) and Critical Temperature Indicators (CTI). The industry is experiencing significant technological transformation through IoT integration, wireless connectivity, and multi-parameter monitoring solutions. Leading TTI manufacturers are investing heavily in eco-friendly biodegradable labels and AI-powered analytics platforms to improve supply chain visibility, reduce product spoilage, and enhance regulatory compliance. For more comprehensive insights, download the FREE report sample: Key Market Drivers and Trends The Time Temperature Indicator market is experiencing remarkable transformation through increasingly sophisticated partnerships between TTI manufacturers and IoT platform companies. These collaborations are driving rapid innovation in smart packaging solutions, creating robust monitoring ecosystems that address critical challenges in cold chain management. Emerging trends demonstrate a multifaceted approach to market development. Manufacturers are intensely focusing on developing Bluetooth-enabled TTI devices that provide real-time alerts and data analytics, integrating advanced color-change chemistry, and creating comprehensive regulatory compliance solutions. The industry is witnessing a significant shift towards sustainable packaging technologies, with particular emphasis on creating biodegradable TTI solutions that seamlessly integrate into existing supply chain systems. Growth Opportunities The market presents significant growth opportunities that extend far beyond traditional temperature monitoring. Integration with IoT platforms offers the potential to create comprehensive cold chain visibility solutions, addressing critical food safety and pharmaceutical compliance challenges. Commercial applications are rapidly expanding beyond basic monitoring, exploring specialized domains such as vaccine distribution, biologics storage, and high-value food transportation. Particularly promising areas include the development of hybrid TTI technologies, advancements in wireless connectivity, and the emergence of AI-powered analytics platforms. The potential for subscription-based monitoring services and specialized compliance solutions represents a significant frontier of market expansion. Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) – Market Challenges Standardization requirements across different regions and complex integration with existing supply chain systems continue to create implementation barriers. Infrastructure development remains a critical constraint, particularly in developing comprehensive cold chain monitoring networks and managing data privacy concerns. Economic challenges include high costs of advanced electronic TTI solutions, limited awareness in developing regions, and the intricate balance between functionality and affordability. Manufacturers must also navigate varying regulatory requirements, address reliability concerns, and work to gain widespread adoption across diverse industry verticals. Segment Insights The global Time Temperature Indicator market demonstrates nuanced segmentation across multiple critical dimensions. The Chemical-based TTI Technology segment is expected to hold the largest market share in 2025 and grow at the highest CAGR through 2035, due to cost-effectiveness and reliability. On the basis of label information, Time Temperature Indicators (TTI) are projected to dominate the market, with Critical Time Temperature Indicators (CTTI) anticipated to grow rapidly due to pharmaceutical compliance requirements. On the basis of end user, Food & Beverage will hold the largest market share in 2025, while Pharmaceutical & Healthcare is projected to grow at a significant CAGR from 2025-2035, highlighting the critical importance of temperature control in drug storage and vaccine distribution. Request a customized research analysis tailored to your specific requirements: Geographic Market Insights North America is expected to hold a significant market share in 2025, attributed to substantial regulatory compliance requirements and advanced cold chain infrastructure. However, the Asia-Pacific region is projected to witness the highest growth rate, driven by rapid industrialization, expanding cold chain infrastructure, and growing awareness of food safety regulations. China leads the region with the largest market share in cold chain logistics, while India follows with significant investments in rural cold storage facilities. Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More)- Competitive Landscape The global time temperature indicator market features a diverse and dynamic competitive landscape. Established packaging and monitoring solution providers are competing alongside innovative technology companies, each pursuing unique approaches to TTI development and smart packaging integration. Key players operating in the overall time temperature indicator market include 3M Company, DeltaTrak Inc., Temptime Corporation (Zebra Technologies), Vitsab International AB, American Thermal Instruments, Timestrip UK Ltd., Insignia Technologies Ltd., SpotSee (Formerly ShockWatch), Berlinger & Co. AG, among others. Related Reports: Cold Chain Equipment Market by Size, Share, Forecasts, & Trends Analysis Temperature Sensors Market Size, Share, & Growth Report 2032 Weather Monitoring Systems Market to Hit $4.49B by 2032 About Meticulous Research We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact:Mr. Khushal BombeMeticulous Market Research Pvt. Ltd.1267 Willis St, Ste 200 Redding,California, 96001, +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- sales@ Our Website: with us on LinkedIn- Source: Logo: View original content:
Malaysian Reserve
an hour ago
- Malaysian Reserve
Industrial Cleaning Solvents Market worth $1.55 billion by 2030
DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ — The report 'Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing and Commercial Offices, Healthcare, Retail & Food Service), and Region – Global Forecast to 2030″, industrial cleaning solvents market size was estimated at USD 1.19 billion in 2024 and is projected to reach USD 1.55 billion by 2030, at a CAGR of 4.55% between 2025 and 2030. Browse in-depth TOC on 'Industrial Cleaning Solvents Market'280 – Tables60 – Figures250 – Pages Download PDF Brochure: The industrial cleaning solvents market is undergoing a significant transformation, shifting from traditional formulations to more environmentally sustainable and low-VOC (volatile organic compound) options. Driven by the ongoing push for stricter environmental regulations and increasing corporate sustainability initiatives, manufacturers are transitioning from harsh chemical-based solvents to biodegradable, non-toxic solutions. This trend is particularly pronounced in industries such as hospitality, retail, and food service, where both workers and customers are frequently exposed to cleaning agents. Today's eco-conscious consumers, along with state and federal regulatory agencies, demand safer, greener products, fostering innovation in solvent formulations that safeguard indoor air quality, worker health, and the environment while still providing comparable cleaning power and operational efficiency performance. The disinfectants segment is projected to be the fastest-growing segment in terms of value in the global industrial cleaning solvents market during the forecast period. The disinfectants segment is projected to be the fastest-growing segment of the global industrial cleaning solvents market, in terms of value, during the forecast period. Since the pandemic, more attention has been given to sanitizing factories, warehouses, and processing units. Solvents of disinfectant grade are used to eliminate pathogens on surfaces, tools, and high-contact areas, making it less likely for people to spread illness. Regular disinfection has become part of the schedule in most industries that manage shared spaces. These disinfectants are preferred because they dry quickly and combat many types of germs, allowing work processes to continue without interruption. As a result of the pandemic, the demand for reliable and rapid-response industrial disinfectant solvents is increasing in various industries. Request Sample Pages: The healthcare industry accounted for the second-largest share of the industrial cleaning solvents market, in terms of value, in 2024. The healthcare industry accounted for the second-largest share of the global industrial cleaning solvents market, in terms of value, in 2024. It is also projected to be the fastest-growing industry during the forecast period. The rapid progress in healthcare across Asia, Africa, and South America is driving an increased demand for industrial cleaning solvents. Hospitals, diagnostic centers, and specialty clinics are being established to accommodate the growing number of patients. These facilities require efficient cleaning systems that adhere to international hygiene standards. As healthcare investments rise, the demand for professional-grade cleaning solvents also grows, supporting the expansion of the market. Europe was the third-largest region in the global industrial cleaning solvents market, in terms of value, in 2024. Europe was the third-largest region of the global industrial cleaning solvents market, in terms of value, in 2024. The robust automotive industry in Germany, France, and Italy drives greater use of industrial cleaning solvents in Europe. These solvents are utilized to maintain machines, clean auto components, degrease parts, and prepare surfaces for coating and painting. As electric vehicle production increases in Europe, the standards for component cleaning are being enhanced. The adoption of automated and robotic systems on the assembly lines boosts the use of high-performing and specialized solvents for precision cleaning in the region. Request Customization: The key players profiled in the report include Exxon Mobil Corporation (US), Shell plc (UK), BASF SE (Germany), Dow Inc. (US), LyondellBasell Industries N.V. (US), Eastman Chemical Company (US), Arkema (France), Celanese Corporation (US), Solvay S.A. (Belgium), Ashland Inc. (US), and Honeywell International Inc. (US). Get access to the latest updates on Industrial Cleaning Solvents Companies and Industrial Cleaning Solvents Market Size Browse Adjacent Market: Specialty Chemicals Market Research Reports & Consulting Related Reports: Solvents Market – Global Forecast to 2029 Industrial Cleaning Chemicals Market – Global Forecast to 2028 Industrial Rubber Market – Global Forecast to 2030 Plate & Frame Heat Exchanger Market – Global Forecast to 2030 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content:
